Skip to content

Dexamethasone In low platelet count in pregnancy

Role Of Dexamethasone In Gestational Thrombocytopenia - A Prospective Randamised Controlled Trial - THROMBODEX

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/030066
Enrollment
60
Registered
2020-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Injection Dexamethasone 12mg: Injection Dexamethasone 12mg IV BD For 3 Days Control Intervention1: Not Applicable: Not Applicable

Sponsors

Shri B M Patil Medical Collage Hospital And Research Center BLDEDU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) pregnant women >37weeks with gestational thrombocytopenia b) Platelet count ranging from 1, 40,000/dl to 50,000/dl.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
1. Timeâ??averaged changes in platelet countTimepoint: 1. Timeâ??averaged changes in platelet count on 24hrs, 48hrs and 5th day

Secondary

MeasureTime frame
1. Total leukocyte count in mother to rule out maternal sepsis 2. Neonatal thrombocytopenia will be looked for by collecting blood sample at birth and on 3rd postnatal day. 3. CRP and Blood Culture within 24 hours of life. 4. Neonatal Outcomes: Need for NICU admission and Respiratory support, Blood Pressure, Metabolic Parameters like Hypoglycemia, Hypocalcaemia, Hyponatremia, Hypernatremia, Intraventricular hemorrhage, Periventricular leukomalacia, Necrotizing Enterocolitis and Death. Timepoint: On Day 1,2 and 4

Countries

India

Contacts

Public ContactDr Laxmi Sangolli

Shri B M Patil Medical Collage And Research Center ,BLDE(DU) Vijayapura

laxmisangolli1983@gmail.com7204760853

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026